Are you over 18 and want to see adult content?
More Annotations
A complete backup of www.asiaerotica.com
Are you over 18 and want to see adult content?
A complete backup of brutal-facesitting.com
Are you over 18 and want to see adult content?
A complete backup of www.malevsfemale.org
Are you over 18 and want to see adult content?
A complete backup of www.www.amateur.tv
Are you over 18 and want to see adult content?
A complete backup of worldwidewives.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://balkanje.com/turske-serije/bezivotni-2018/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/amanet-2014/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/naslednica-epizoda-29/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/moj-dom-2019/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/organizacija-epizoda-11/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/ljubav-vjera-nada/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/turske-serije/moja-kcerka-2018/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/latino-serije/crveni-orao/
Are you over 18 and want to see adult content?
A complete backup of https://balkanje.com/latino-serije/hermanos-2014/
Are you over 18 and want to see adult content?
Text
EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution TS - JOIN MEETING - EXCELRA EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution TS - JOIN MEETING - EXCELRA EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in earlyEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
NEWSROOM-LATEST FROM EXCELRA November 05, 2020. Hyderabad, India; Cambridge, MA; November 05/ Thursday /2020: Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, Read more. COVID-19 RESOURCE HUB COVID-19 Biomarker Database. This ‘Open-Access’ resource is excerpted from our GOBIOM platform – the world’s largest biomarker intelligence database. The database is a compilation of manually curated biomarkers from published clinical trials, evaluating potential drugs or biologics for the treatment of SARS-CoV-2. Thedatabase
CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you.EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PLATFORM DEVELOPMENT, WORKFLOW INTEGRATION, CLOUD SERVICES Excelra is a leading technology solutions company equipped to deliver data driven application development , enterprise workflow Integration, bespoke cloud services, advanced visualization for R&D data and other DevOps related services. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. TS - JOIN MEETING - EXCELRA EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution TS - JOIN MEETING - EXCELRA EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution TS - JOIN MEETING - EXCELRA EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in earlyEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
NEWSROOM-LATEST FROM EXCELRA November 05, 2020. Hyderabad, India; Cambridge, MA; November 05/ Thursday /2020: Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, Read more. COVID-19 RESOURCE HUB COVID-19 Biomarker Database. This ‘Open-Access’ resource is excerpted from our GOBIOM platform – the world’s largest biomarker intelligence database. The database is a compilation of manually curated biomarkers from published clinical trials, evaluating potential drugs or biologics for the treatment of SARS-CoV-2. Thedatabase
CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you.EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PLATFORM DEVELOPMENT, WORKFLOW INTEGRATION, CLOUD SERVICES Excelra is a leading technology solutions company equipped to deliver data driven application development , enterprise workflow Integration, bespoke cloud services, advanced visualization for R&D data and other DevOps related services. RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. TS - JOIN MEETING - EXCELRA EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
LEADERSHIP TEAM
Anandbir is the Chief Executive Officer at Excelra. Having joined as Director for New Business Development and Initiatives in 2014, Anandbir has spearheaded the service line strategy, incubation, expansion and innovation of the portfolio at Excelra. RWE & BIG DATA REALIZATION Meaningful real-world evidence (RWE) is becoming indispensable for securing patient and prescriber access to products. One of the biggest challenges in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD)sources.
EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN Introduction to drug target biology and its role in drug discovery. Drug discovery and development is a long, expensive and risky process. On average it takes roughly 12 years and around $2.6 billion todevelop a
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
LEADERSHIP TEAM
Anandbir is the Chief Executive Officer at Excelra. Having joined as Director for New Business Development and Initiatives in 2014, Anandbir has spearheaded the service line strategy, incubation, expansion and innovation of the portfolio at Excelra. RWE & BIG DATA REALIZATION Meaningful real-world evidence (RWE) is becoming indispensable for securing patient and prescriber access to products. One of the biggest challenges in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD)sources.
EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN Introduction to drug target biology and its role in drug discovery. Drug discovery and development is a long, expensive and risky process. On average it takes roughly 12 years and around $2.6 billion todevelop a
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
NEWSROOM-LATEST FROM EXCELRA Excelra and IIT-Kharagpur announce a multi-year collaboration aimed at accelerating research in Drug Repurposing. The alliance will leverage diverse skill-sets and domain expertise of the two partners and integrate Natural Language Processing (NLP) and Machine Learning (ML) technology in Excelra’s Drug Repurposing engine.EVENTS - EXCELRA
Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
LEADERSHIP TEAM
Anandbir is the Chief Executive Officer at Excelra. Having joined as Director for New Business Development and Initiatives in 2014, Anandbir has spearheaded the service line strategy, incubation, expansion and innovation of the portfolio at Excelra. IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. RWE & BIG DATA REALIZATION Meaningful real-world evidence (RWE) is becoming indispensable for securing patient and prescriber access to products. One of the biggest challenges in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD)sources.
VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Excelra Value & Evidence team provides solutions to support our clients in generating and communicating the required evidence around the effectiveness, safety and the true value of TS - JOIN MEETING - EXCELRA VALUE EVIDENCE SERVICES BROCHURE Value Evidence Communication We package analytical insights into coherent and impactful global value dossiers, slide presentations, and other market-access collaterals, tailor EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
NEWSROOM-LATEST FROM EXCELRA November 05, 2020. Hyderabad, India; Cambridge, MA; November 05/ Thursday /2020: Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, Read more.EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
TS - JOIN MEETING - EXCELRA VALUE EVIDENCE SERVICES BROCHURE Value Evidence Communication We package analytical insights into coherent and impactful global value dossiers, slide presentations, and other market-access collaterals, tailor EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs.LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
UNCOVERING THE PRODUCT VALUE STORY The Excelra Approach Uncovering the Product Value Story - Value Dossier Case Study The Purpose To develop the Academy of Managed Care Pharmacy (AMCP) dossier for communicating the value of DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs.LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
UNCOVERING THE PRODUCT VALUE STORY The Excelra Approach Uncovering the Product Value Story - Value Dossier Case Study The Purpose To develop the Academy of Managed Care Pharmacy (AMCP) dossier for communicating the value of DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. NEWSROOM-LATEST FROM EXCELRA November 05, 2020. Hyderabad, India; Cambridge, MA; November 05/ Thursday /2020: Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, Read more.EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PUBLICATIONS
12 Aug 2016. Sunil Kumar Sahu, Ashish Anand, Krishnadev Oruganty and Mahanandeeshwar Gattu. Learn More. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
TS - JOIN MEETING - EXCELRA EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs.LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
UNCOVERING THE PRODUCT VALUE STORY The Excelra Approach Uncovering the Product Value Story - Value Dossier Case Study The Purpose To develop the Academy of Managed Care Pharmacy (AMCP) dossier for communicating the value of DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR. CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs.LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
UNCOVERING THE PRODUCT VALUE STORY The Excelra Approach Uncovering the Product Value Story - Value Dossier Case Study The Purpose To develop the Academy of Managed Care Pharmacy (AMCP) dossier for communicating the value of DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
CONTACT US – EXCELRA We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. NEWSROOM-LATEST FROM EXCELRA November 05, 2020. Hyderabad, India; Cambridge, MA; November 05/ Thursday /2020: Excelra, a leading global data science & data analytics company, and Cellarity, a flagship pioneering company working on the development of a new generation of medicines to treat diseases at the level of cell behaviours, Read more.EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PUBLICATIONS
12 Aug 2016. Sunil Kumar Sahu, Ashish Anand, Krishnadev Oruganty and Mahanandeeshwar Gattu. Learn More. PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM. VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
TS - JOIN MEETING - EXCELRA EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
PUBLICATIONS
12 Aug 2016. Sunil Kumar Sahu, Ashish Anand, Krishnadev Oruganty and Mahanandeeshwar Gattu. Learn More. OUR EDGE - ARTIFICIAL INTELLIGENCE (AI) TO HELP SCALE Excelra turns these vast data-pools into meaningful insights that unlock operational efficiencies, and increase the speed and accuracy of drug discovery, clinical development, regulatory approval, reimbursement, and market access. The life sciences industry is at the cusp of a data science revolution. We help our partners adapt theirbusiness
EXCELRA | COVID-19-BIOMARKER-DATABASE Excelra | Covid-19-Biomarker-Database IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM.SLR & META-ANALYSIS
SLR & Meta-Analysis. An extension of our clinical trial outcomes data services, we curate safety and efficacy outcomes data from published clinical trials. These datasets can be used for network meta-analysis (NMA) to estimate the comparative efficacy and safety of some interventions. Starting from your research question, Excelra assembles VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
PUBLICATIONS
12 Aug 2016. Sunil Kumar Sahu, Ashish Anand, Krishnadev Oruganty and Mahanandeeshwar Gattu. Learn More. OUR EDGE - ARTIFICIAL INTELLIGENCE (AI) TO HELP SCALE Excelra turns these vast data-pools into meaningful insights that unlock operational efficiencies, and increase the speed and accuracy of drug discovery, clinical development, regulatory approval, reimbursement, and market access. The life sciences industry is at the cusp of a data science revolution. We help our partners adapt theirbusiness
EXCELRA | COVID-19-BIOMARKER-DATABASE Excelra | Covid-19-Biomarker-Database IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM.SLR & META-ANALYSIS
SLR & Meta-Analysis. An extension of our clinical trial outcomes data services, we curate safety and efficacy outcomes data from published clinical trials. These datasets can be used for network meta-analysis (NMA) to estimate the comparative efficacy and safety of some interventions. Starting from your research question, Excelra assembles VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning across EXCELRA | DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONSERVICESOUR EDGEABOUT USRESOURCESCONTACT USTRANSLATIONAL Excelra is a leading data science company that empowers innovation across the drug development value chain. Leveraging cutting-edge AI/ML technologies we analyze biomedical and real-world big data to galvanize data-driven decisions. AI-DRIVEN DRUG DISCOVERY Excelra is a leading data science company focused on leveraging AI/ML tools for drug discovery. We provide custom chemistry curation services and offer the world's largest medicinal chemistry intelligence database-GOSTAR.EXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
RWE & BIG DATA REALIZATION RWE & Big Data Realization. The biggest challenge in using RWE for a wide range of applications is the heterogeneity and uneven quality of various real-world data (RWD) sources. Curation, harmonization, and integration of unstructured data sets are the critical need of the hour. Excelra’s expert curators use a techno-human approach tounlock
LEADERSHIP TEAM
Gabriele (known as Gabi to everyone) is a results-driven executive with more than 20 years of experience in the Life Science industry and in-depth knowledge of the pharmaceutical and biotechnology sector. She is a proven leader in building and leading high-performance global teams while drawing on her skills in strategy development & execution EXCELRA DRUG REPURPOSING SERVICES Drug Repurposing at Excelra Drug Repurposing or Repositioning (DR) is a strategy in drug development that aims at identifying new therapeutic opportunities for existing drugs. EXCELRA | DRUG DISCOVERY & DEVELOPMENT INSIGHTS Data-driven insights across the drug discovery and development value chain to accelerate Biotech and Pharma innovation. DRUG TARGET DOSSIER: TARGET INTELLIGENCE FOR DATA DRIVEN A Target Dossier is a compilation of all the information that is critical for assessing target safety and risk, and for developing suitable mitigation strategies. The dossier also helps to prepare, plan, and execute a data driven informed drug discovery and development program. Strategies to advance drug discovery. Phenotypicscreening.
GOBIOM - UNDERSTANDING THE PLATFORM'S UTILITY IN CLINICAL GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and putative biomarkers, providing critical insights into the relationship between biomarker and disease. GOBIOM as a one-stop platform provides clinical and pre-clinical information on biochemical, genomic, imaging, metabolite, clinical scoring scales and cellular markers spanning acrossEXCELRA | RESOURCES
We Provide Global Structure Activity Relationship Database with Translational Biology Services and Complete analytics of Clinical &Market Access.
EVENTS - EXCELRA
Events - Excelra | Data Science to Empower Life Science Innovation. Considering the evolving COVID-19 pandemic and the WHO ICAO guidelines on international travel, Excelra will only be participating in ‘virtual events’. We will share further updates as the situationdevelops.
PRECISION ONCOLOGY AND CLINICAL PHARMACOLOGY Excelra's AI/ML platforms empower precision oncology enabling data driven indication prioritization, patient stratification and drug combination prediction. We provide curation and consulting in clinical pharmacology and pharmacometrics offering the largest clinical trialoutcomes database.
PUBLICATIONS
12 Aug 2016. Sunil Kumar Sahu, Ashish Anand, Krishnadev Oruganty and Mahanandeeshwar Gattu. Learn More. OUR EDGE - ARTIFICIAL INTELLIGENCE (AI) TO HELP SCALE Excelra turns these vast data-pools into meaningful insights that unlock operational efficiencies, and increase the speed and accuracy of drug discovery, clinical development, regulatory approval, reimbursement, and market access. The life sciences industry is at the cusp of a data science revolution. We help our partners adapt theirbusiness
EXCELRA | COVID-19-BIOMARKER-DATABASE Excelra | Covid-19-Biomarker-Database IN SILICO BIOMARKER DISCOVERY & DRUG REPURPOSING Excelra is a global leader in the application of AI/ML tools for biomarker discovery, drug repurposing and systems bioinformatics. We provide custom biology curation services and offer the world's largest biomarker intelligence database-GOBIOM.SLR & META-ANALYSIS
SLR & Meta-Analysis. An extension of our clinical trial outcomes data services, we curate safety and efficacy outcomes data from published clinical trials. These datasets can be used for network meta-analysis (NMA) to estimate the comparative efficacy and safety of some interventions. Starting from your research question, Excelra assembles VALUE & EVIDENCE, HEOR, LIFE CYCLE MANAGEMENT Starting with a regulatory evidential need/gap analysis, we conceptualize the right modeling strategy to deliver rigorous and customized HEOR analytical consulting. We leverage our expertise in quantifying value by modeling disease outcomes in executing custom cost-effectiveness analyses, cost-benefit analyses, and budget impactanalyses.
COMPETITIVE LANDSCAPE ANALYSIS FOR GO NO-GO DECISION Data driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development Case Study Project Objective The objective of the analysis was to determine the competitive position of their novel antibody in early* Services
* Discovery
* Data Science Driven Drug Discovery * Target Identification * Target Dossier Services * Chemistry Curation Services* GOSTAR
__
* Translational
* Biomarker Discovery * Drug Repositioning * Life Cycle Management * Systems Biology Informatics * Biology Curation Services* GOBIOM
__
* Clinical
* Precision Oncology Informatics * Clinical Pharmacology and Pharmacometrics * Clinical Trial Outcomes Database__
* Value Evidence
* Outcomes Research
* Epidemiology Modeling* Economic Modeling
* Value Evidence Communication * RWE & Big Data Realization * SLR & Meta-analysis__
* Technology
* Platform and Product Development * Enterprise Workflow Integration* Cloud Services
* Visualization and Dashboards__
__ * Our Edge
* About Us
* Leadership Team
* Newsroom
* Events
__
* Resources
* Brochures & Case Studies* Videos
* Blog
* Publications
* Social Wall
* COVID-19 Drug Repurposing Database__ * Contact us
Excelra | Data Science to Empower LifeScience Innovation
* Services
* Discovery
* Data Science Driven Drug Discovery * Target Identification * Target Dossier Services * Chemistry Curation Services* GOSTAR
* Translational
* Biomarker Discovery * Drug Repositioning * Life Cycle Management * Systems Biology Informatics * Biology Curation Services* GOBIOM
* Clinical
* Precision Oncology Informatics * Clinical Pharmacology and Pharmacometrics * Clinical Trial Outcomes Database* Value Evidence
* Outcomes Research
* Epidemiology Modeling* Economic Modeling
* Value Evidence Communication * RWE & Big Data Realization * SLR & Meta-analysis* Technology
* Platform and Product Development * Enterprise Workflow Integration* Cloud Services
* Visualization and Dashboards* Our Edge
* About Us
* Leadership Team
* Newsroom
* Events
* Resources
* Brochures & Case Studies* Videos
* Blog
* Publications
* Social Wall
* COVID-19 Drug Repurposing Database* Contact us
__ Contact Us
Close
Enter your
text here
DATA SCIENCE TO EMPOWER LIFE SCIENCE INNOVATIONINSIGHTS
DIGITAL WISDOM IN THE ERA OF VALUE AND PERSONALIZATION*
Discovery
DISCOVERY
*
Translational
TRANSLATIONAL
*
Clinical
CLINICAL
*
Value Evidence
VALUE EVIDENCE
Discovery
From the discovery of safe and effective targets to the identification of most promising drug candidates, we accelerate drug development by leveraging our state-of-the-art AI/ML powered discovery engine, coupled with our deep domain expertise in pharmacology and medicinalchemistry.
Learn More
Translational
We integrate a systems biomedicine perspective with our advanced computational biomarker discovery platform to decipher disease & drive beneficial therapeutic innovations across indications. Founded on our holistic drug-disease-target understanding, we empower the cost-effective repurposing of drugs that have been shelved, failed, in-development, or even approved, towards novel indications.Learn More
Clinical
Wielding advanced AI/ML and deep learning algorithms, we empower indication prioritization, patient stratification, and drug combination prediction, to personalize and maximize treatment benefits for all cancer patients. Our pharmacology modeling and simulation services further help optimize dosing, clinical trial design, and predict clinical outcomes, enabling new therapeutics to advance efficiently through clinical testing.Learn More
Value Evidence
Excelra enables outcome-based market access strategies through solutions including pharmacoeconomic modeling to demonstrate effectiveness, and cogent value communication narratives to frame the healthcare dialogue with key stakeholders. Additionally, we mine Real-World Data (RWD) to build epidemiology and market forecast models to uncover population patterns of health and disease.Learn More
OUR EDGE
DATA + DOMAIN + DATA SCIENCE Excelra’s solutions are powered by a unique Dual Competence model that synergizes our multi-disciplinary scientific acumen with cutting-edge technology and data science spanning AI/ML, Deep Learning and NLP/Text Mining Algorithms. Furthermore, we offer stand-alone technology services to streamline life science R&D including Application Development, Advanced Visualizations, and Enterprise Workflow Integration.Learn More
DATA
TAMING THE LIFE SCIENCE DATA DELUGE*
Discovery
DISCOVERY
*
Translational
TRANSLATIONAL
*
Clinical
CLINICAL
*
Value Evidence
VALUE EVIDENCE
Discovery
Excelra’s GOSTAR is the world’s largest structure-activity-relationship database that houses comprehensive intelligence on bio-active compounds in discovery, development, and market. Meticulously curated by hundreds of scientists from a plethora of public sources, GOSTAR facilitates rapid target validation, virtual screening, and lead optimization to accelerate drug development. Explore our end-to-end customized chemistry content management and data curation solutions.Learn More
Translational
Excelra’s GOBIOM is the world’s largest repository of disease biomarkers, carefully curated from a vast array of sources in exploratory, preclinical and clinical domains. GOBIOM is an essential biomarker toolkit for drug development, aiding in target identification, safety/toxicity profiling, patient stratification, and clinical outcome prediction. Explore our custom curation and content management services encompassing big data from pan-omics and multiscale systems biology.Learn More
Clinical
Excelra’s proprietary Clinical Trial Outcome Database (CTOD) is an exhaustive and synoptic compilation of published clinical trial outcomes across more than 90 therapeutic areas; which enables rational trial design and Go/No-Go decisions. We also provide custom curation services across preclinical toxicity reports, clinical trial protocolsand outcomes.
Learn More
Value Evidence
Regulatory grade, analysis-ready Real World Evidence (RWE) can support regulatory decisions, uncover new off-label uses, establish historical controls, and enable outcome-based reimbursement decisions. Excelra synthesizes Real-World Evidence by curating, integrating and harmonizing healthcare datasets like EMRs, claims, registries, etc. into a standard data model or customized to dovetail into clientrequirements.
Learn More
SERVICES
DISCOVERY
* Data Science Driven Drug Discovery * Target Identification * Target Dossier Services * Chemistry Curation Services* GOSTAR
TRANSLATIONAL
* Biomarker Discovery * Drug Repositioning * Life Cycle Management * Systems Biology Informatics * Biology Curation Services* GOBIOM
CLINICAL
* Precision Oncology Informatics * Clinical Pharmacology and Pharmacometrics * Clinical Trial Outcomes DatabaseVALUE EVIDENCE
* Outcomes Research
* Epidemiology Modeling* Economic Modeling
* Value Evidence Communication * RWE & Big Data Realization * SLR & Meta-analysisTECHNOLOGY
* Platform and Product Development * Enterprise Workflow Integration* Cloud Services
* Visualization and DashboardsPLATFORMS
* GOSTAR
* GOBIOM
Terms of Use | Privacy Policy © 2020, Excelra , AllRights Reserved.
The website is best experienced on the latest version of Chrome, Firefox, Safari and Internet Explorer browsers* __LinkedIn
* __Facebook
* __Twitter
* __email
We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. Ok Privacy policy Click here to downloadDownload
×
Click here to downloadDownload
CLOSE
Your Name (required) Your Email (required)Your Number
Conference
ACS Fall 2020 National Meeting & ExpoEFMC-ISMC 2020 – XXVI EFMC International Symposium on Medicinal ChemistryDiscovery On TargetThe 9th Annual Drug Repostioning, Repurposing & Rescue ConferenceAnnual Artificial Intelligence In Drug Development CongressACOP11BioDataISPOREurope
Your Message
×
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Download
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
Click here to downloadDownload
CLOSE
CLOSE
We use cookies to enable website functionality, understand the performance of our site, provide social media features, and serve more relevant content to you. OkPrivacy policyDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0